FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Martin Avenue Pharmacy Tri-mix SEST 4 Recall

Tri-mix SEST 4, 30 mg/1

Martin Avenue Pharmacy, Inc. · Naperville, IL

Risk level
Class II
Reported by FDA
Nov 5, 2014
Recall ID
D-0154-2015
Check your lot numberHow we source this data

Summary

Martin Avenue Pharmacy recalled Tri-mix SEST 4 starting Aug 27, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0154-2015 on Nov 5, 2014. Reason: Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.

Product description

Tri-mix SEST 4, 30 mg/1.5 mg/400 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.

Lot numbers, UPCs & expiration codes

Lot Number: 07202014@5, Exp 9/15/2014; 07152014@1, Exp 9/30/2014

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0154-2015
Classification
Class II
Status
Terminated
Recall initiated
Aug 27, 2014
FDA report date
Nov 5, 2014
Quantity
110 mL
Recall type
Voluntary: Firm initiated
Recalling firm
Martin Avenue Pharmacy, Inc.

Original FDA data

Every field from FDA enforcement report D-0154-2015, exactly as published.

Show all FDA fields
City
Naperville
State
IL
Status
Terminated
Country
United States
Event ID
69152
Address
1247 Rickert Dr
Code information
Lot Number: 07202014@5, Exp 9/15/2014; 07152014@1, Exp 9/30/2014
Postal code
60540-1008
Report date
Nov 5, 2014
Product type
Drugs
Recall number
D-0154-2015
Classification
Class II
Recalling firm
Martin Avenue Pharmacy, Inc.
Product quantity
110 mL
Termination date
May 31, 2018
Reason for recall
Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tri-mix SEST 4, 30 mg/1.5 mg/400 mcg/mL (papaverine, phentolamine mesylate, alprostadil) injectable packaged in a clear glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.
Distribution pattern
Nationwide
Recall initiation date
Aug 27, 2014
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Oct 29, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0154-2015, published Nov 5, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls